On Demand Webinar
The past 12 months have accelerated the innovation cycle within biopharma, which has led to novel introductions of approaches and technologies to engage with key healthcare stakeholders. Many of these transformations have quickly proven to be both effective and efficient and, given their favorable impact and adoption, are expected to outlast the COVID-19 era. The remote interaction models rooted in personalization and advanced analytics will reshape how life sciences companies maximize their engagement models in the future. Balancing digital health and the human connection will be a critical success factor for the industry to achieve the best results in their efforts.
Join VMS BioMarketing on May 19 as we host a webinar in partnership with MM+M to discuss the innovations from the COVID era that are expected to be a part of our new normal, and the best practices we’re seeing in the industry as engagement models are being designed for the new era, beyond the pandemic.
Learning Objectives:
Offered Free by: VMS BioMarketing
See All Resources from: VMS BioMarketing